nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0648	0.0648	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0508	0.0508	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—TNFRSF25—sclerosing cholangitis	0.0455	0.0455	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.0427	0.0427	CbGpPWpGaD
Irbesartan—JUN—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.0409	0.0409	CbGpPWpGaD
Irbesartan—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.034	0.034	CbGpPWpGaD
Irbesartan—PTGS1—Eicosanoid Synthesis—GGT1—sclerosing cholangitis	0.0334	0.0334	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—BCL2L11—sclerosing cholangitis	0.0332	0.0332	CbGpPWpGaD
Irbesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0324	0.0324	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.0307	0.0307	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—BCL2L11—sclerosing cholangitis	0.0287	0.0287	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—sclerosing cholangitis	0.0287	0.0287	CbGpPWpGaD
Irbesartan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0277	0.0277	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.0269	0.0269	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.0236	0.0236	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.0233	0.0233	CbGpPWpGaD
Irbesartan—JUN—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.0224	0.0224	CbGpPWpGaD
Irbesartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0213	0.0213	CbGpPWpGaD
Irbesartan—UGT1A3—Phase II conjugation—GGT1—sclerosing cholangitis	0.0209	0.0209	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.0186	0.0186	CbGpPWpGaD
Irbesartan—PTGS1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.0185	0.0185	CbGpPWpGaD
Irbesartan—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.0181	0.0181	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.0164	0.0164	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.0148	0.0148	CbGpPWpGaD
Irbesartan—JUN—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.0148	0.0148	CbGpPWpGaD
Irbesartan—JUN—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.0147	0.0147	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—HIF1A—sclerosing cholangitis	0.0141	0.0141	CbGpPWpGaD
Irbesartan—UGT1A3—NRF2 pathway—GGT1—sclerosing cholangitis	0.014	0.014	CbGpPWpGaD
Irbesartan—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.0139	0.0139	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.0135	0.0135	CbGpPWpGaD
Irbesartan—JUN—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.0135	0.0135	CbGpPWpGaD
Irbesartan—UGT1A3—Biological oxidations—GGT1—sclerosing cholangitis	0.0123	0.0123	CbGpPWpGaD
Irbesartan—CYP2C8—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.012	0.012	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.0118	0.0118	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—HIF1A—sclerosing cholangitis	0.00991	0.00991	CbGpPWpGaD
Irbesartan—CYP2C9—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00975	0.00975	CbGpPWpGaD
Irbesartan—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00833	0.00833	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00744	0.00744	CbGpPWpGaD
Irbesartan—PTGS1—Biological oxidations—GGT1—sclerosing cholangitis	0.0069	0.0069	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00646	0.00646	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.00552	0.00552	CbGpPWpGaD
Irbesartan—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	0.0053	0.0053	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ABCB4—sclerosing cholangitis	0.00511	0.00511	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00488	0.00488	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—GGT1—sclerosing cholangitis	0.00446	0.00446	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00417	0.00417	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00394	0.00394	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	0.00366	0.00366	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—GGT1—sclerosing cholangitis	0.00363	0.00363	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.0034	0.0034	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	0.0031	0.0031	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.0031	0.0031	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.0029	0.0029	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ABCB4—sclerosing cholangitis	0.00288	0.00288	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00265	0.00265	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GOT2—sclerosing cholangitis	0.00243	0.00243	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.00239	0.00239	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00231	0.00231	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GGT1—sclerosing cholangitis	0.0021	0.0021	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GOT1—sclerosing cholangitis	0.0021	0.0021	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCB4—sclerosing cholangitis	0.00186	0.00186	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00171	0.00171	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00168	0.00168	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	0.00153	0.00153	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCB4—sclerosing cholangitis	0.00151	0.00151	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00139	0.00139	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GOT2—sclerosing cholangitis	0.00137	0.00137	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00132	0.00132	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	0.00129	0.00129	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00119	0.00119	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GGT1—sclerosing cholangitis	0.00118	0.00118	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GOT1—sclerosing cholangitis	0.00118	0.00118	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000998	0.000998	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000984	0.000984	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GOT2—sclerosing cholangitis	0.000883	0.000883	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GGT1—sclerosing cholangitis	0.000762	0.000762	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GOT1—sclerosing cholangitis	0.000762	0.000762	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	0.000725	0.000725	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT2—sclerosing cholangitis	0.000719	0.000719	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	0.000626	0.000626	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	0.000626	0.000626	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GGT1—sclerosing cholangitis	0.000621	0.000621	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT1—sclerosing cholangitis	0.000621	0.000621	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	0.000614	0.000614	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	0.00053	0.00053	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	0.00053	0.00053	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	0.000474	0.000474	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	0.000409	0.000409	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	0.000409	0.000409	CbGpPWpGaD
